BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Clinical Trials

AdvanCell Doses First Patient in 212Pb-ADVC001 Clinical Trial for Metastatic Prostate Cancer in Australia

“The first patient dosed with an AdvanCell therapeutic candidate represents a major milestone for the Company, our scientists, clinical trial sites, ...

November 09, 2023 | News

KN026 was Granted Breakthrough Therapy Designation by CDE

Gastric cancer is one of the most common gastrointestinal malignancies in the world, and the number of new cases and deaths of gastric cancer in China...

November 08, 2023 | News

Menarini Group and SciClone Pharma Partner to Bring ORSERDU® to China for Advanced Breast Cancer

ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations,...

November 08, 2023 | News

PolyActiva Reports Positive Glaucoma Implant Trial in Australia

Melbourne ophthalmology company PolyActiva is developing a unique biodegradable ocular implant that provides 6 months of sustained drug deli...

November 06, 2023 | News

GC Biopharma Seeks South Korean MFDS Approval for World's First Recombinant Anthrax Vaccine.

'GC1109' contains protective antigen (PA) as its active pharmaceutical ingredients produced by recombinant DNA technology which delivers 2 types of protein...

November 06, 2023 | News

Sanyou Bio Cheers KangaBio's IND Approval for Next-Gen IL-12 Prodrug Cancer Immunotherapy

These trials will primarily focus on late-stage solid tumors and the effectiveness will either be evaluated as a standalone therapy or in combination with ...

November 06, 2023 | News

Medidata NEXT New York to Unveil New Vision for Life Sciences Innovation

Medidata to announce latest innovations to accelerate drug and device development to bring treatments to patients sooner Signature event brings together...

November 03, 2023 | News

Curocell Completes Korea's First Phase 2 Clinical Trial for Next-Generation CAR-T

Anbal-cel argeting DLBCL completes phase 2 trial Anticipation growing over Korea's first CAR-T therapy ahead of regulatory review Commerci...

November 02, 2023 | News

Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction

Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading bioph...

November 02, 2023 | News

YS Biopharma Completes Pivotal Phase 3 Enrollment for PIKA Rabies Vaccine Trial

Rabies has an almost 100% fatality rate upon emergence of clinical symptoms. Each year, it claims the lives of approximately 59,000 individuals in ...

November 01, 2023 | News

First Patient Enrolled in Phase III Trial of Boan Biotech's Nivolumab

Nivolumab is a monoclonal antibody that can enhance the immune response of T cells against tumors by preventing the programmed cell death 1 (PD-1) receptor...

October 31, 2023 | News

Everest Medicines Receives Approval in Macau for Nefecon® in Primary IgA Nephropathy

Everest Medicines (HKEX 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercializ...

October 30, 2023 | News

First Patient Dosed in Europe for Phase 3 Study of Henlius Anti-PD-1 mAb Serplulimab

According to GLOBOCAN 2020, lung cancer (LC) is the second most commonly diagnosed and the first mortality cancer around the world. There were 2.2 million ...

October 26, 2023 | News

PharmaKure submits for Alzheimer's Disease Combined Drug Clinical Trial

PharmaKure, a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease and other neurodegenerative diseases...

October 25, 2023 | News

Stay Connected